EMERGENT BIOSOLUTIONS INC. COMMON STOCK

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

09 Jul 2024 12:29:29 By NetDania Notify

Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan

09 Jul 2024 07:30:04 By Nasdaq GlobeNewswire

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

08 Jul 2024 11:14:06 By NetDania Notify

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

02 Jul 2024 12:02:06 By NetDania Notify

Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

02 Jul 2024 09:43:07 By Nasdaq GlobeNewswire

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

02 Jul 2024 08:13:43 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million

20 Jun 2024 07:00:57 By Nasdaq GlobeNewswire

Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day

06 Jun 2024 09:02:45 By Nasdaq GlobeNewswire

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024

10 May 2024 07:17:11 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports First Quarter 2024 Financial Results

01 May 2024 16:57:22 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

01 May 2024 16:10:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

01 May 2024 11:03:28 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

30 Apr 2024 17:26:55 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

22 Apr 2024 08:05:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

28 Mar 2024 08:15:03 By Nasdaq GlobeNewswire

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

25 Mar 2024 08:05:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

06 Mar 2024 16:31:01 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 Feb 2024 09:45:22 By NetDania Notify